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A B S T R A C T
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, represents a major animal health issue. In the United
Kingdom and the Republic of Ireland, European badgers (Meles meles) have been shown to act as a reservoir ofM.
bovis infection, hindering the eradication of bTB in livestock. The availability of suitable diagnostic assays,
particularly those that may be applied in a “trap-side” setting, would facilitate the implementation of a wider
range of disease control strategies. Here we evaluate the Dual Path Platform (DPP) VetTB assay, a lateral-flow
type test for detecting antibodies toM. bovis antigens (MPB83 and ESAT-6/CFP-10). Both serum and whole blood
were evaluated as diagnostic samples. Additionally, two methods were evaluated for interpretation of test results
(qualitative interpretation by eye and quantitative measurement using an optical reader). The antibody response
to MPB83 detected by the DPP VetTB assay increased significantly following experimental M. bovis infection of
badgers, whilst the response to ESAT-6/CFP-10 showed no significant change. In sera from TB-free captive and
naturally M. bovis infected wild badgers the MPB83 response exhibited a sensitivity of 55 % by eye and quan-
titative reader (95 % CI: 40–71 and 38–71, respectively), with slightly lower specificity when read by eye (93 %
compared to 98 %; 95 % CI: 85–100 and 90–100, respectively). In whole blood, the DPP VetTB assay MPB83
response exhibited a sensitivity of 65 % (95 % CI: 50–80) when interpreted by eye and 53 % (95 % CI: 36–69)
using quantitative values, whilst the specificity was 94 % and 98 % respectively (95 % CI: 88–100 and 90–100).
Comparison with contemporaneous diagnostic test results from putatively naturally infected and TB-free badgers
demonstrated varying levels of agreement. Using sera from naturally M. bovis infected and TB-free badgers, with
post mortem confirmation of disease status, the DPP VetTB assay exhibited a sensitivity of 60 % (95 % CI: 41–77)
when interpreted using quantitative values (specificity 95 %; 95 % CI: 76–100), and 67 % (95 % CI: 50–84) when
read by eye (specificity 95 %; 95 % CI: 86–100). Further work is required to robustly characterize the DPP VetTB
assay’s performance in a wider selection of samples, and in the practical and epidemiological contexts in which it
may be applied.
1. Introduction
Bovine tuberculosis (bTB), caused by Mycobacterium bovis, re-
presents an on-going challenge for the farming industry in parts of
Europe, North America and New Zealand (Gormley and Corner, 2018),
and is recognised as a re-emerging animal- and public- health issue in a
number of low and middle income countries (Olea-Popelka et al.,
2017). In those countries that have implemented statutory control
programmes, the eradication of bTB in livestock may be hindered by
the existence of a reservoir of infection in wildlife (Gormley and Corner,
2018). In the United Kingdom and the Republic of Ireland, the Eur-
opean badger (Meles meles) has been shown to act as such a reservoir of
infection, and is implicated in the transmission of infection to cattle
(Palmer, 2013). One of the primary challenges in tackling M. bovis in-
fection in wildlife is the lack of sufficiently sensitive and specific di-
agnostic tests, which may be used to assess disease prevalence, identify
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infected individuals or populations for control purposes or to monitor
the success of intervention strategies (Maas et al., 2013).
The “gold-standard” for TB diagnosis in badgers is a detailed post
mortem examination and culture of tissues for viable M. bovis. Studies of
naturally infected badger populations in both the United Kingdom and
the Republic of Ireland have demonstrated that a significant proportion
of infected animals do not have macroscopic lesions, so histological
examination and bacteriological culture of tissues are essential in order
to maximise the sensitivity of diagnosis (Crawshaw et al., 2008; Murphy
et al., 2010). Infection can also be diagnosed by the culture of M. bovis
from clinical samples taken from live animals (Gallagher and Clifton-
Hadley, 2000). However, this approach lacks sensitivity, in part due to
the intermittent nature of detectable bacterial excretion among infected
animals (Chambers et al., 2002). Nonetheless, the specificity of culture
from samples collected from live animals has been estimated by Baye-
sian analysis to be 99.8 %, making a positive culture result highly di-
agnostically informative (Drewe et al., 2010).
Dalley et al. (2008) developed an interferon-gamma enzyme im-
munoassay (ELISA) for badgers, which exhibited a sensitivity of 81 %
(at a specificity of 94 %). However, assays based on the cell-mediated
immune response require extensive laboratory facilities, and impose
constraints on the handling of blood samples, which makes them lo-
gistically difficult to implement (Waters et al., 2007). These factors
currently make this type of assay impractical for use in the widespread
diagnosis of M. bovis infection in badgers, particularly where a rapid
“trap-side” result is required as part of an applied management pro-
gramme.
A number of serological assays have been developed for TB diag-
nosis in live badgers, though their sensitivity is generally relatively low
(reviewed in Chambers, 2009, 2013). This includes an immuno-chro-
matographic lateral flow assay, known as the BrockTB Stat-Pak®
(Chembio Diagnostic Systems Inc., Medford, NY, USA). This assay was
based on the detection of IgG and IgM antibodies to a mixture of re-
combinant mycobacterial antigens, including MPB83, ESAT-6 and CFP-
10 (Greenwald et al., 2003). The sensitivity of the BrockTB Stat-Pak in a
panel of sera from TB positive and negative badgers (confirmed by post
mortem examination and culture) was estimated at 53 %, with a spe-
cificity of 95 % (Greenwald et al., 2003). A subsequent study demon-
strated lower sensitivity (49 % at a specificity of 93 %) relative to
culture for M. bovis following necropsy (Chambers et al., 2008). How-
ever, these authors also demonstrated that the sensitivity of the test was
significantly higher (66–78%) in animals with more severe disease,
which are considered to be those most likely to excrete M. bovis.
Consequently, there is a need to identify new serological approaches
to the diagnosis of TB in badgers. In particular, it is desirable that these
approaches should be appropriate for rapid “trap-side” diagnosis of
infection in live badgers, as this would facilitate the implementation of
a wider range of disease control strategies (e.g. Smith et al., 2016).
Hence the capacity to use whole blood, as an alternative to serum, is
desirable for any new test (e.g. O’Brien et al., 2009).
The Dual-Path Platform (DPP®) VetTB assay, manufactured by
Chembio Diagnostic Systems Inc., is a rapid lateral-flow type test for
antibodies to TB infection in cervids and elephants. The assay detects
IgG antibodies, and has two immuno-chromatographic test lines, se-
parately detecting responses to MPB83 and ESAT-6/CFP-10 fusion
protein. Data on the performance of the DPP VetTB assay have been
generated for various species of deer (Lyashchenko et al., 2013), South
American camelids (Lyashchenko et al., 2011), wild boar (Che’ Amat
et al., 2015) and elephants (Greenwald et al., 2009; Lyashchenko et al.,
2012). The performance of the assay appears to vary significantly be-
tween species, with published sensitivity estimates ranging from 59.3 to
61.5% in wild boar (Sus scrofa) to 71.9 % in naturally infected white-
tailed deer (Odocoileus virginianus).
Here we report the first evaluation of the Chembio Dual-Path
Platform (DPP) VetTB assay for the detection of M. bovis infection in
badgers. We have evaluated the diagnostic performance of the DPP
VetTB assay using panels of samples (both serum and whole blood)
collected from both naturally and experimentally infected badgers, and
have compared the assay’s performance with existing diagnostic
methods.
2. Materials and methods
A retrospective study design was employed to evaluate the diag-
nostic performance of the DPP VetTB assay, utilizing existing serum and
whole blood samples (i.e. convenience samples, as defined in STARD
guidelines; Cohen et al., 2016). Further details are given in Table 1.
2.1. Samples from TB-free captive badgers (Weybridge)
Samples were collected from captive badgers free of M. bovis in-
fection, for assessment of DPP VetTB assay specificity. These animals
were originally trapped in counties of England (Essex and Suffolk)
within the “low risk” area for TB incidence in the cattle population,
where there is considered to be no significant reservoir of TB in wildlife
(Defra, 2014). Once in captivity, these animals were tested using the
parallel and serial application of a combination of existing diagnostic
assays. Badgers were tested on three consecutive occasions, at ap-
proximately monthly intervals, using an interferon-gamma ELISA
(Dalley et al., 2008), with all results negative. Concurrently, clinical
Table 1
Samples used for evaluating the diagnostic performance of the DPP VetTB assay.
Name Brief description Purpose Number of samples
Serum Whole blood
+ve −ve +ve −ve
Weybridge Samples from TB-free captive badgers Assessment of specificity N/A 53 N/A 53
Further assessment of specificity N/A 36 N/A 381
VES Samples from badgers experimentally infected with M. bovis Relative performance of diagnostic antigens and antibody
kinetics following experimental infection
722 N/A 722 N/A
BVS Samples from wild badgers naturally infected with M. bovis,
confirmed by culture
Estimates of sensitivity in naturally infected badgers 38 N/A 40 N/A
Woodchester Park Samples from badgers in an intensively studied wild
population, with existing diagnostic test results
Diagnostic performance of the DPP VetTB assay relative to
existing tests in a high bTB prevalence region
109 142 1091 1421
BVFT Samples from naturally infected and TB-free badgers with
detailed post mortem results
Sensitivity and specificity of the DPP VetTB assay in sera from
badgers with detailed post mortem results
30 21 – –
N/A: Not applicable; VES: Vaccine Efficacy Study; BVS: Badger Vaccine Study; BVFT: Badger Vaccination Field Trial.
1 Whole blood samples tested without freeze-thawing.
2 Samples from 12 experimentally infected badgers collected on six consecutive occasions.
R.T. Ashford, et al. Preventive Veterinary Medicine 180 (2020) 105005
2
samples (tracheal mucous, laryngeal swabs, rectal swabs and urine)
were collected for bacteriological culture to detect the presence of ex-
creted M. bovis (Chambers et al., 2017 for methodological details), with
all samples negative. Finally, TB-free captive badgers were subse-
quently used in experimental infection studies (see below), with de-
tailed post mortem examination and bacteriological culture of tissues.
Molecular typing of M. bovis recovered from tissues (spoligotyping and
VNTR analysis, see Chambers et al., 2017) confirmed that only the
strain used for challenge was present, providing further confirmation of
the M. bovis-free status of these individuals, prior to experimental in-
fection.
2.2. Samples from badgers experimentally infected with M. bovis (VES)
Samples from experimentally infected badgers were collected
during a vaccine efficacy study (VES) conducted as part of a programme
of work to develop an oral BCG vaccine formulation for badgers
(Chambers et al., 2014). Only samples collected from non-vaccinated
experimentally infected animals (n = 12) were included for analysis in
the current study. Briefly, badgers were confirmed to be free of TB (as
described above), prior to experimental infection via endo-bronchial
installation of approximately 103 CFU of M. bovis (Chambers et al.,
2017). Subsequently, blood samples were collected at approximately
fortnightly intervals. Twelve weeks after experimental infection bad-
gers were euthanased and submitted to a detailed post mortem ex-
amination of gross pathology, with bacteriological culture and histo-
logical examination of tissues (Chambers et al., 2017). All these
experimentally infected animals exhibited gross pathology, confirmed
by culture and histology, consistent with established M. bovis infection
(data not shown).
2.3. Samples from wild badgers naturally infected with M. bovis, confirmed
by culture (BVS)
Samples from culture-confirmed naturally infected badgers, for
preliminary estimates of relative sensitivity, were collected during the
Badger Vaccine Study (BVS), a clinical field study of the safety of intra-
muscular BCG vaccination (Chambers et al., 2011). Briefly, a popula-
tion of badgers in a high bTB incidence area of the south-west of
England were trapped regularly over a period of four years. At each
capture, individuals were anesthetised and blood and clinical samples
(tracheal aspirate, urine, faeces and swabs from any wounds) for cul-
ture of viable M. bovis, were collected. Contemporaneous BrockTB Stat-
Pak test results, conducted on sera shortly after sample collection, were
available for these animals (Chambers et al., 2011). Serum and blood
samples from a panel of non-vaccinated control animals with culture
confirmed excretion of viable M. bovis in clinical samples were selected
for testing by DPP VetTB assay. To confirm that freezing of whole blood
samples had not had a deleterious impact onM. bovis specific antibodies
present, they were also tested using the BrockTB Stat-Pak assay, ac-
cording to the manufacturer’s protocol for serum, to enable comparison
with contemporaneous results for the matched sera.
2.4. Samples from badgers in an intensively studied wild population, with
existing diagnostic test results (Woodchester Park)
Additional samples for the assessment of the DPP VetTB assay were
collected from an intensively studied population of badgers in
Woodchester Park (WP) Gloucestershire, a high bTB prevalence area in
the south-west of England (Delahay et al., 2000). As part of the on-
going study of this population, badgers are live-trapped four times per
year. The infection status of each trapped individual was assessed on
the basis of the BrockTB Stat-Pak serological test, interferon-gamma
ELISA and bacteriological culture from clinical samples (tracheal and
oesophageal aspirates, urine, faeces and swabs from any bite wounds
and abscesses present). For the purposes of the current study, 251
serum and whole blood samples collected during the 2014–2015 trap-
ping season (May–January) were tested in parallel, using the DPP
VetTB assay.
2.5. Samples from naturally infected and TB-free badgers with detailed post
mortem results (BVFT)
Surplus serum samples collected during the Badger Vaccination
Field Trial (BVFT), to investigate the impact of oral vaccination of free-
living badgers against naturally transmitted M. bovis infection in the
Republic of Ireland (Gormley et al., 2017), were used to assess the
performance of the DPP VetTB assay. Detailed post mortem examination
results, with bacteriological culture for M. bovis and histological ex-
amination of tissues, were available for 51 animals. Twenty-one ani-
mals were identified as TB negative on this basis and DPP VetTB assay
results from these badgers were compared to those from 30 individuals
with culture and/or histologically confirmed M. bovis infection. Con-
temporaneous BrockTB Stat-Pak results were also available for these
animals (Gormley et al., 2017).
2.6. Sample collection and storage
In all cases, blood for serological testing was collected from the
jugular vein of anaesthetised badgers. In the case of serum, blood was
collected using either plain or serum separator (SST) vacutainer tubes
(BD, Plymouth, UK). Following transfer to the laboratory, tubes were
centrifuged (2600 g for 10 min) and serum removed from the clotted
sample. In the case of whole blood, samples were collected using he-
parinised vacutainer tubes (BD, Plymouth, UK).
Serum and whole blood samples were aliquoted after collection into
multiple small volume single-use aliquots (100 μL–500 μL) for sub-
sequent testing, to avoid the need for multiple freeze-thaw cycles. In the
case of whole blood collected from Woodchester Park badgers, and
additional whole blood from captive TB-free badgers for assessment of
specificity, samples were tested directly after collection (≤6 h),
without freeze-thawing. Frozen serum and whole blood aliquots were
stored at −80 °C.
2.7. DPP VetTB assay protocol
The DPP VetTB assay was performed as described by the manu-
facturer (DPP® VetTB Assay for Cervids, Chembio Diagnostic Systems
Inc., Medford, NY, USA), with a number of minor modifications, pri-
marily relating to the volume of sample used. Preliminary data (not
shown) indicated that the serum volume recommended by the manu-
facturer (5 μL) resulted in sub-optimal sensitivity, relative to the
BrockTB Stat-Pak. Consequently, samples from experimentally infected
badgers (VES), and from captive TB-free badgers (Weybridge), were
used to compare the performance of the assay with three different
serum volumes (5 μL, 10 μL and 30 μL, see Supplementary Material). All
subsequent evaluation work utilised a serum sample volume of 30 μL,
with an additional drop of sample diluent added to the sample + buffer
well (well 1) on the assay device (see Supplementary Material). Test
results were read 15–20 min after addition of buffer to the buffer well
(well 2).
The protocol used for whole blood was as described by the manu-
facturer for the DPP® VetTB Assay for Elephants, using 10 μL of whole
blood. Some degree of clotting and/or haemolysis was frequently ob-
served following freeze-thawing of whole blood samples (Weybridge,
BVS and VES animals), despite the addition of heparin during collec-
tion. Consequently, samples were thoroughly mixed following thawing,
prior to the removal of the required volume for testing.
The DPP VetTB assay has two test lines (plus a control line), de-
tecting antibodies to MPB83 (Line 1) and ESAT-6/CFP-10 fusion protein
(Line 2). Assay results were read both “by eye” (based upon inter-
pretation by the operator performing the test) and using an optical
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reading device supplied by the test manufacturer (Opticon DPP test
reader, Chembio Diagnostic Systems Inc, USA), which measures relative
light unit (RLU) values. Results read by eye were recorded as positive or
negative, with a further semi-quantitative scoring of the strength of the
antigen specific response (see Supplementary Material). Only assays
with a valid control line result were included in subsequent analyses.
2.8. Data analysis
RLU values were analysed using non-parametric statistics
(Friedman’s test, Spearman’s correlation and two-sample Kolmogorov-
Smirnov test). Data were log(x+1)-transformed where required (e.g.
for parametric statistical analysis by one-way ANOVA and repeated
measures two-way ANOVA). The significance of differences in the
proportion of tests positive/negative was assessed using Fisher’s exact
test. Sensitivity and specificity of quantitative data, relative to existing
diagnostic results, were estimated by receiver operating characteristic
(ROC) analysis (Greiner et al., 2000). Working cut-offs for RLU values
were derived from ROC analysis, by selecting the threshold with the
highest likelihood ratio. Agreement between diagnostic tests was
quantified using Cohen’s kappa statistic, with interpretations as de-
scribed by Dohoo et al. (2009). Statistical tests were implemented in
either GraphPad Prism version 7.3 (GraphPad Software, La Jolla, CA,
USA) or Minitab version 17 (Minitab Inc., PA, USA).
3. Results
3.1. Relative performance of diagnostic antigens and antibody kinetics
following experimental infection (VES)
The performance of the VetTB DPP assay was initially evaluated
using samples collected at five time-points following experimental in-
fection (VES), to assess the relative diagnostic performance of the an-
tigenic targets included in test lines one and two (MPB83 and ESAT-6/
CFP-10 respectively). Line 1 (MPB83) specific antibody levels increased
significantly in serum following experimental infection (Fig. 1a;
Friedman test, F = 44.18, P<0.0001). Conversely, Line 2 (ESAT-6/
CFP-10) specific antibody levels in serum showed no significant in-
crease over time (Fig. 1b; Friedman test, F = 10.63, P> 0.05). The
same pattern of change in antigen specific antibodies was observed in
whole blood samples collected during the same study (Fig. 1c and d).
Line 1 (MPB83) specific antibody levels measured by the DPP VetTB
assay increased significantly in whole blood following experimental
infection, whilst no significant change was observed in Line 2 (ESAT-6/
CFP-10) specific antibodies (Friedman test, F = 49.35, P<0.0001 and
F = 4.69, P>0.05 for Line 1 and Line 2 respectively).
3.2. Estimates of sensitivity and specificity in culture confirmed naturally
infected (BVS) and TB-free captive (Weybridge) badgers
Data from BVS and Weybridge badgers were used to generate pre-
liminary estimates of sensitivity and specificity for the VetTB DPP
assay, and to derive working cut-off thresholds for the quantitative
reader RLU values. Summarised relative sensitivity and specificity es-
timates are shown in Table 2. In this panel of sera, Line 1 of the VetTB
DPP assay exhibited a sensitivity of 55.3 % (95 % CI: 38.3–71.4) at a
specificity of 98.1 % (95 % CI: 89.9–100.0) (Fig. 2). Consistent with
responses observed in experimentally infected badgers, Line 2 results
for the same samples were less diagnostically informative, with a
maximum specificity of 66.0 % (95 % CI: 51.7–78.5) achieved (data not
shown). The areas under the ROC curves for Line 1 and Line 2 were
0.96 (95 % CI: 0.92–1.00) and 0.66 (95 % CI: 0.54 to 0.78), respec-
tively. When read by eye, the sensitivity of the Line 1 response in sera
was 55.3 % (95 % CI: 39.5–71.1) at a specificity of 92.5 % (95 % CI:
85.3–99.6). Contemporaneous diagnostic test data for the BVS serum
samples demonstrated that the BrockTB Stat-Pak assay exhibited a
sensitivity of 65.0 % (95 % CI: 50.2–79.8).
The performance of the DPP VetTB assay in whole blood samples
collected from the same animals was very similar, with a sensitivity of
52.5 % (95 % CI: 36.1–68.5) at a specificity of 98.1 % (95 % CI:
86.9–100.0) in Line 1 (Fig. 2). As observed in sera from the same ani-
mals, Line 2 results for whole blood were less diagnostically in-
formative, with the maximum specificity achieved being 62.3 % (95 %
CI: 47.9–75.2) (data not shown). The area under the ROC curve for Line
1 and Line 2 was 0.78 (95 % CI: 0.68–0.89) and 0.68 (95 % CI:
0.57–0.80), respectively. When read by eye, the sensitivity of the Line 1
response in whole blood was 65.0 % (95 % CI: 50.2–79.8) at a speci-
ficity of 94.3 % (95 % CI: 88.1–100.0). The BrockTB Stat-Pak assay
performed on the BVS whole blood samples exhibited a sensitivity of
62.5 % (95 % CI: 47.5–77.5).
The specificity of the DPP VetTB assay was subsequently further
investigated using additional panels of sera and fresh whole blood
samples from TB-free captive (Weybridge) badgers. For 36 sera the DPP
VetTB assay (Line 1 only) exhibited a specificity of 100.0 % when read
by eye, and 97.2 % (95 % CI: 91.9–100.0) when read using the quan-
titative reader (applying the working cut-off value obtained from ROC
analysis). In 38 fresh whole blood samples from TB-free captive
(Weybridge) badgers the DPP VetTB assay exhibited a specificity of
94.7 % (95 % CI: 87.6–100.0), both when read by eye and when read
using the quantitative reader (applying the previously established cut-
off value). Although the samples were not matched, there was no dif-
ference in the specificity of the DPP VetTB assay (Line 1) between fresh
and frozen whole blood samples (Fisher’s exact test, P> 0.05 both for
results read by eye and using RLU values) or in the distribution of RLU
values (Kolmogorov-Smirnov test, P> 0.05).
3.3. Diagnostic performance of the DPP VetTB assay relative to existing
tests in a high bTB prevalence region (Woodchester Park)
Parallel DPP VetTB assay data for serum and whole blood samples,
plus contemporaneous diagnostic test results, were available from 251
Woodchester Park badger captures, representing 134 individual ani-
mals (median 2 captures per animal; range 1–5). In the case of Line 1
(MPB83) there was a strong association between quantitative results for
the DPP assay in serum and whole blood samples (Spearman’s r = 0.57,
95 % CI: 0.48−0.65, P<0.0001). Notably, there were a significant
number of samples for which a non-zero MPB83 result was obtained in
whole blood but not serum, indicating the higher average background
values generated with this sample type (Fig. 3). The correlation be-
tween results in serum and whole blood was not significant in the case
of Line 2 (ESAT-6/CFP-10; Spearman’s r = 0.06, 95 % CI: −0.07 to
0.19, P> 0.05).
Cohen’s kappa values for the two methods of interpreting DPP
VetTB assay result (read by eye and quantitative reader) indicated al-
most perfect agreement for Line 1 (0.90 and 0.85 for serum and whole
blood respectively). Comparisons between results read by eye and
quantitative reader were not performed for Line 2, as its performance
did not warrant further investigation. For Line 1, the agreement be-
tween sample types (serum and whole blood) was 0.57 (moderate)
when read by eye and 0.61 (substantial) when read by quantitative
reader. For Line 2, the agreement between sample types (serum and
whole blood) was 0.09 (slight) when read by eye.
In this dataset there was no significant difference between the
proportion of positive results generated by reading DPP VetTB tests by
eye and using the quantitative reader with cut-off values established
previously for Line 1 (Fisher’s exact test, P> 0.05 for both serum and
whole blood). The level of agreement observed between the VetTB DPP
assay (Line 1 only) and contemporaneous diagnostic test data was
variable (Table 3). The highest agreement was observed in animals
identified as positive on the basis of bacteriological culture of clinical
samples, with between 73.7 and 78.9 % of these samples also positive
by DPP VetTB assay (Table 3). The largest discrepancy in positive
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results was observed between the BrockTB Stat-Pak and DPP VetTB
assays, with the former assay identifying a larger proportion of in-
dividuals as positive when compared to the DPP VetTB assay in either
serum or whole blood (Table 3). In serum from animals that were ne-
gative by all contemporaneous test data (culture, interferon-gamma
ELISA and BrockTB Stat-Pak) 2.1 % and 0.7 % were identified as po-
sitive by DPP VetTB assay read by eye and quantitative reader, re-
spectively. In whole blood the proportion of otherwise negative samples
identified as positive by DPP VetTB assay rose to 9.9 % and 4.9 % for
tests read by eye and by quantitative reader respectively (Table 3).
Cohen’s kappa values calculated for DPP VetTB assay results and
contemporaneous data from existing diagnostic tests in badgers from
Woodchester Park ranged from fair (0.23) to moderate (0.52). The
lowest levels of agreement were observed between DPP VetTB assay
and bacteriological culture of clinical samples (kappa between 0.23 and
0.37: see Table 3). However, agreement between bacteriological culture
and all formats of the DPP VetTB assay was higher than between culture
and the BrockTB Stat-Pak assay (kappa = 0.16). Agreement between
the BrockTB Stat-Pak and DPP VetTB assays ranged from 0.44 to 0.48
(moderate).
3.4. Sensitivity and specificity of the DPP VetTB assay in sera from badgers
with detailed post mortem results (BVFT)
Quantitative DPP VetTB assay results from 21 TB-free badgers and
30 with culture and/or histologically confirmed M. bovis infection were
available for ROC analysis, in order to provide estimates of sensitivity
and specificity relative to post mortem data (Fig. 4). In this panel of sera
the DPP VetTB assay (Line 1 only) exhibited optimal performance (i.e.
maximum likelihood ratio) at a sensitivity of 60.0 % (95 % CI:
40.6–77.3), and a specificity of 95.2 % (95 % CI: 76.2–99.9).
In the panel of samples with post mortem confirmation of M. bovis
infection (n = 30) the DPP VetTB assay exhibited a sensitivity of 66.7
% (95 % CI: 49.8–83.5) when read by eye, which was identical to that
of the BrockTB Stat-Pak. In the panel of samples from animals con-
firmed to be free of M. bovis infection (n = 21) the specificity of the
DPP VetTB assay was estimated to be 95.2 % (95 % CI: 86.1–100.0)
when read by eye, compared to 100 % in the BrockTB Stat-Pak.
Agreement between the DPP VetTB (Line 1) and BrockTB Stat-Pak assay
Fig. 1. Antigen specific antibody responses measured by DPP VetTB assay in badgers (n = 12), at five time-points following experimental infection. Fig. 1a and b
show the Line 1 (MPB83) and Line 2 (ESAT-6/CFP-10) responses, respectively, detected in serum. Fig. 1c and 1d show the Line 1 and Line 2 responses, respectively,
detected in whole blood. Plotted values are relative light units (RLU), with median (horizontal lines).
Table 2
Summary of relative sensitivity and specificity values (with 95 % confidence
intervals) for DPP VetTB assay Line 1 (MPB83 specific) responses in serum and
whole blood from culture-confirmed naturally infected (BVS) and TB-free
captive (Weybridge) badgers.
Sample type Sensitivity Specificity Working cut-
off a
Eye RLU Eye RLU
Serum 55.3 55.3 92.5 98.1 71.7
39.5–71.1 38.3–71.4 85.3–99.6 89.9–100.0
Whole blood 65.0 52.5 94.3 98.1 154.0
50.2–79.8 36.1–68.5 88.1–100.0 89.9–100.0
aWorking cut-off value based on ROC analysis (threshold with the highest
likelihood ratio).
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was substantial (Cohen’s kappa = 0.71 and 0.63 for tests read by eye
and quantitative reader, respectively).
4. Discussion
The work presented here provides an initial evaluation of the
Chembio Dual-Path Platform (DPP) VetTB assay for the detection of M.
bovis infection in badgers. We have evaluated the diagnostic perfor-
mance of the DPP VetTB assay using panels of samples collected from
both naturally and experimentally infected badgers, and animals known
or suspected to be free of M. bovis infection, and compared the assay’s
performance with existing diagnostic methods. This study employed a
Fig. 2. Performance of the Chembio DPP VetTB assay in a panel of sera (a & b) and whole blood (c & d) from TB-free captive and culture confirmed naturally infected
badgers, showing (a & c) log-transformed relative light unit (RLU) values for Line 1 (MPB83) with working cut-off (dashed horizontal line) and mean values (solid
horizontal lines) and (b & d) ROC curves based on RLU data.
Fig. 3. Antigen specific antibody responses measured by DPP VetTB assay in parallel serum and whole blood samples from 251 badger captures at Woodchester Park.
Plotted values show log-transformed relative light units (RLU) for Line 1 (MPB83) and Line 2 (ESAT-6/CFP-10) responses.
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retrospective design, making use of samples collected during previous
and on-going studies, and as such there are a number of limitations.
One of these is that it was not possible to entirely standardise the sto-
rage of sample panels prior to testing. The duration of serological
sample storage may potentially impact sample integrity, with repeated
freeze-thawing, in particular, known to adversely impact the perfor-
mance of antibody based assays for tuberculosis (Boadella and
Gortazar, 2011). In the current study, the impact of freeze-thawing was
minimised by aliquoting samples into single-use volumes prior to sto-
rage. Additionally, samples were stored under conditions (−80 °C)
considered to be optimal for stabilising IgG antibodies (e.g. Neumann
and Bonistalli, 2009). Nonetheless, future work should ideally employ a
study design which explicitly controls the duration of storage when
evaluating the performance of the DPP VetTB assay in different sample
panels. Furthermore, in the current study two panels of whole blood
samples (Woodchester Park and additional TB-free captive Weybridge
badgers) were tested fresh, whereas other whole blood samples were
stored frozen prior to testing. Whilst the samples were not matched,
there was no evidence of a significant difference in the performance of
the DPP Vet TB assay in fresh and frozen whole blood. However, future
work should seek to explicitly compare the impact of freeze-thawing
whole blood samples on test performance, particularly if the DPP VetTB
assay is to be applied as a trap-side test (using freshly collected whole
blood samples). A further limitation of the current study is that samples
were tested by several different operators, in two separate locations. To
mitigate this, data were generated using an established standard oper-
ating procedure, with training in the protocol provided to all operators.
Additionally, the performance of the optical reader device was cali-
brated between locations. However, future validation work should seek
to explicitly address issues of both intra- and inter- operator reliability.
Initial evaluation of the diagnostic performance of the DPP VetTB
assay in badgers was undertaken using samples from experimentally
infected animals. This evaluation demonstrated that the antigenic tar-
gets included in the two lines of the DPP assay (MPB83 and ESAT-6/
CFP-10 fusion protein, respectively) exhibited very different diagnostic
performance, with ESAT-6/CFP-10 specific antibody responses showing
no significant increase with disease progression. Previous studies have
demonstrated that MPB83 specific antibodies are dominant in the ser-
ological response to M. bovis infection in badgers (Greenwald et al.,
2003; Lesellier et al., 2009a, b). However, it has also been shown by
multi-antigen print immuno-assay (MAPIA) that a smaller proportion of
animals additionally respond to the antigens ESAT-6 and CFP-10, both
individually and as a fusion protein (Greenwald et al., 2003; Lesellier
et al., 2008, 2009a,b). Studies in cattle have demonstrated that in-
dividual profiles of reactivity to specific antigens may evolve with
disease progression (e.g. Lyashchenko et al., 2017). Data from experi-
mentally infected badgers in the current study show no evidence of a
temporal change in responses to the ESAT-6/CFP-10 fusion antigen
included in the DPP VetTB assay (e.g. Fig. 1b). However, the relatively
short time-scale of the experimental infection protocol used in the
current study may not fully replicate the longer-term kinetics of the
antibody response exhibited in naturally infected animals. Hence it
would be valuable to study the relative performance of sero-diagnostic
antigens over a longer period of infection.
Studies in other species have demonstrated that IgM responses toM.
bovis infection can be detected earlier than IgG responses, though they
also wane more quickly (e.g. Waters et al., 2006; Lyashchenko et al.,
2017). For this reason it has been suggested that assays detecting both
IgM and IgG responses, such as the Chembio BrockTB Stat-Pak, may
exhibit greater sensitivity than those detecting IgG alone, such as the
DPP VetTB assay (Waters et al., 2006). In the current study, samples
from experimentally infected badgers indicated that detectable MPB83-
specific antibody responses in serum developed between two and four
weeks after infection in the majority of animals. This is consistent with
previous studies of IgG antibodies to MPB83 in experimentally infected
Table 3
Agreement between contemporaneous diagnostic test data and DPP VetTB
assay results in 251 serum and whole blood samples collected from
Woodchester Park badgers. DPP VetTB assay results (Line 1 only) for both
serum and whole blood were read by eye and using a quantitative reader to
record relative light units (RLU). Agreement is presented as percentage of in-
dividuals in each group positive by DPP VetTB assay, relative to con-
temporaneous diagnostic test results, and measured by Cohen’s kappa statistic.
Serum Whole blood
Eye RLU Eye RLU
Culture positive (n = 19) % pos 73.7 73.7 78.9 73.7
Kappa 0.34 0.37 0.23 0.26
Interferon-gamma ELISA positive (n =
41)
% pos 63.4 63.4 73.2 70.7
Kappa 0.49 0.52 0.40 0.46
BrockTB Stat-Pak positive (n = 101) % pos 43.6 42.6 55.4 51.5
Kappa 0.44 0.45 0.46 0.48
Interferon-gamma ELISA and BrockTB
Stat-Pak positive (n = 36)a
% pos 66.7 69.4 75.0 72.2
Kappa 0.45 0.44 0.48 0.50
Negative by all tests (culture, interferon-
gamma ELISA and BrockTB Stat-Pak)
(n = 142)b
% pos 2.1 0.7 9.9 4.9
Kappa – – – –
a Cohen’s kappa values calculated based on parallel interpretation of inter-
feron-gamma ELISA and BrockTB Stat-Pak assays (see Drewe et al., 2010).
b Not possible to calculate Cohen’s kappa values for animals negative by all
tests.
Fig. 4. a) Quantitative DPP VetTB assay Line1 (MPB83) results for BVFT sera with post mortem confirmation of disease status, and (b) ROC analysis based on these
data. Values plotted in (a) are log-transformed relative light unit (RLU) values, with working cut-off (dashed horizontal line) and means (solid horizontal lines).
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badgers, which demonstrated that responses were first detected by
ELISA at three to four weeks following challenge (Lesellier et al., 2008,
2009b). Hence there is no indication, from the current study, that
measurement of the IgG antibody responses alone has negatively im-
pacted the ability of the DPP Vet TB assay to detect the early stages of
infection.
The current evaluation has allowed us to assess the sensitivity of the
DPP VetTB assay relative to the BrockTB Stat-Pak, which is no longer
commercially available. It should be noted, however, that the con-
fidence intervals around estimates of sensitivity overlap, and hence we
cannot make definitive conclusions on the relative performance of the
two assays (DPP VetTB and BrockTB Stat-Pak). This highlights the
challenge of generating validation data for diagnostic assays in wildlife
populations, where the availability of reference samples from animals
of known disease status is often limited (OIE, 2014).
Selecting representative reference samples for the intended valida-
tion purpose is an important consideration when evaluating diagnostic
assay performance in wildlife species. In particular, samples should be
obtained from sub-clinically infected animals if the test undergoing
validation is to be used in apparently healthy animals (OIE, 2014). In
the present study the panel of samples used to generate preliminary
estimates of relative sensitivity were collected from naturally infected
live badgers, identified by isolation of M. bovis from clinical samples.
However, samples from animals in which bacterial excretion has been
detected may not be representative of the true range of infection states
in a wild population, as these individuals are typically at a more ad-
vanced stage of disease progression and hence are also most likely to
have a detectable antibody response to M. bovis (e.g. Chambers et al.,
2008).
In addition to providing estimates of the sensitivity and specificity
of the DPP VetTB assay, we have attempted to assess agreement be-
tween this test and existing diagnostic methods used on live animals,
with samples from an intensively studied free-living badger population
in a high bTB incidence area (Woodchester Park). Agreement, measured
as the proportion of animals DPP VetTB assay positive in a group
identified by existing test data, was highest for badgers which were
culture positive, for all DPP VetTB assay formats (74–79%). The pro-
portion of animals positive by the DPP VetTB assay was lowest in the
sub-set of Woodchester Park badgers identified as positive on the basis
of contemporaneous BrockTB Stat-Pak results alone (43%–55%, de-
pending on DPP VetTB assay format). Agreement between the two tests
was moderate in this group (Cohen’s kappa 0.44–0.48). This result is
somewhat unexpected, due to the similarity between the two tests, both
of which are lateral-flow format assays detecting antibodies targeting
the same sero-dominant antigens. Whilst this may reflect true differ-
ences in the relative sensitivity of the assays, other factors may also be
of significance. Recent Bayesian analysis of the relative sensitivity of
the BrockTB Stat-Pak using data generated in the Woodchester Park
population has indicated that the sensitivity of this assay is higher than
that demonstrated by previous studies, exceeding that of the interferon-
gamma ELISA in this population (Buzdugan et al., 2016). This runs
counter to orthodoxy regarding the relative sensitivity of assays based
on the humoral and cellular immune responses for detecting TB infec-
tion (e.g. Kunnath-Velayudhan and Gennaro, 2011), and hence could
conceivably reflect something specific to the application of the BrockTB
Stat-Pak assay in the Woodchester Park population. Interestingly, pre-
vious studies have demonstrated an increasing temporal trend in sero-
prevalence within this population, relative to prevalence based on
bacteriological culture (Delahay et al., 2013). Further investigation is
required to disentangle the cause, or causes, of the observed dis-
crepancy between BrockTB Stat-Pak and DPP VetTB assay performance
in this population.
Some discrepancy was also observed between DPP VetTB assay re-
sults and existing assays in badgers from Woodchester Park that were
negative by all contemporaneous tests (interferon-gamma ELISA,
BrockTB Stat-Pak and bacterial culture). Parallel interpretation of these
tests has been estimated to provide a negative predictive value of 97 %
(Drewe et al., 2010), and hence provides substantial confidence in the
probable disease status of this sub-set of animals. Thus the proportion of
animals identified as positive by the DPP VetTB assay in whole blood
when read by eye (9.9 %), is somewhat higher than predicted by esti-
mates of the assay’s specificity in other panels of samples. One potential
explanation for the higher proportion of putative “false-positives” ob-
served in whole blood samples when read by eye is inter-operator dif-
ferences in the interpretation of the test. Whilst this factor was miti-
gated as far as possible (see above) it was not explicitly incorporated
into the design of the current study, and warrants further investigation.
There is some evidence, from the data presented here, that the
specificity of the DPP VetTB assay in sera and whole blood may be
higher when using the quantitative reader (applying the working cut-off
values established) than when interpreting tests by eye. A number of
factors will influence the degree of concordance observed between the
two methods. Firstly, the cut-off values applied to quantitative results
will clearly influence the number of positive tests identified. Further
work, using larger panels of samples and incorporating additional po-
pulations, may demonstrate that optimal sensitivity and specificity can
be achieved by adjusting the cut-off values applied here. A second set of
factors that are likely to significantly influence the degree of con-
cordance observed between DPP VetTB assay results based on quanti-
tative values and when read by eye are the conditions under which the
test is performed. If the DPP VetTB assay were applied as a “trap-side”
test it is reasonable to assume that it might often be undertaken in poor
or inconsistent light conditions. The effect of such variables on the
accuracy of reading tests by eye requires further evaluation.
The use of quantitative values for the interpretation of the DPP
VetTB assay provides a number of additional benefits. Importantly,
quantitative values allow the trade-off between sensitivity and specifi-
city to be adjusted, according to the requirements of the intended ap-
plication. Where prevalence is relatively high (such as during the initial
stages of a disease control programme), it may be desirable to favour
higher sensitivity over specificity, in order to identify the maximum
number of infected animals. Conversely, specificity becomes more im-
portant as prevalence decreases, and in such scenarios it may be de-
sirable to increase specificity at the cost of sensitivity, in order to reduce
the number of false positives (Greiner et al., 2000; Buzdugan et al.,
2016).
Finally, the current study has confirmed the existence of a small
proportion of animals ostensibly free of M. bovis infection which
nonetheless produce detectable antibody responses to specific antigens.
As described, it is considered unlikely that any of these captive TB-free
(Weybridge) animals were harboring an undetected M. bovis infection.
Similar false-positive reactions before disease challenge have been seen
in previous experimental studies in the UK (Lesellier et al., 2008) and
Republic of Ireland (Aznar et al., 2014). The likely explanation for such
reactions is serological cross-reaction following exposure to related
mycobacteria expressing MPB83, or other environmental bacteria ex-
pressing a homologous protein. Cross-reactions in serological tests for
M. bovis have been reported in a number of species, and attributed to
several non-tuberculous mycobacteria (e.g. Buddle et al., 2010). The
precise cause of such false-positive reactions in badgers requires further
investigation.
5. Conclusions
This study provides an initial evaluation of the performance of the
DPP VetTB assay in badgers, which act as a wildlife reservoir of M.
bovis. The DPP VetTB assay format possesses a number of characteristics
that make it particularly attractive, such as the small sample volume
needed, minimal laboratory infra-structure requirements, potential to
be applied as a “trap-side” test and the option to test whole blood, as
well as serum. Despite the limitations of the study, these results indicate
that the DPP VetTB assay provides a useful diagnostic tool, with
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performance characteristics approximately equivalent to those ob-
served in previously described serological assays. However, confidence
intervals around estimates of both sensitivity and specificity are cur-
rently relatively large, and further work is required to increase con-
fidence in the estimated performance of the DPP VetTB assay. This
study highlights the importance of carefully evaluating diagnostic as-
says for wildlife species in the practical and epidemiological contexts in
which they will be applied. This is particularly important if the assay is
intended to be used as part of a disease control intervention.
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